- Home
- CTEV vs ITOS Comparison
CTEV vs ITOS Comparison
Compare CTEV & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTEV
- ITOS
- Stock Information
- Founded
- CTEV 1980
- ITOS 2011
- Country
- CTEV United States
- ITOS United States
- Employees
- CTEV N/A
- ITOS N/A
- Industry
- CTEV
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTEV
- ITOS Health Care
- Exchange
- CTEV NYSE
- ITOS Nasdaq
- Market Cap
- CTEV 295.8M
- ITOS 270.7M
- IPO Year
- CTEV N/A
- ITOS 2020
- Fundamental
- Price
- CTEV $21.10
- ITOS $6.88
- Analyst Decision
- CTEV Hold
- ITOS Strong Buy
- Analyst Count
- CTEV 1
- ITOS 3
- Target Price
- CTEV $19.00
- ITOS $26.00
- AVG Volume (30 Days)
- CTEV 147.3K
- ITOS 384.6K
- Earning Date
- CTEV 05-07-2025
- ITOS 03-05-2025
- Dividend Yield
- CTEV N/A
- ITOS N/A
- EPS Growth
- CTEV N/A
- ITOS N/A
- EPS
- CTEV N/A
- ITOS N/A
- Revenue
- CTEV $930,624,000.00
- ITOS $35,000,000.00
- Revenue This Year
- CTEV N/A
- ITOS N/A
- Revenue Next Year
- CTEV N/A
- ITOS $121.70
- P/E Ratio
- CTEV N/A
- ITOS N/A
- Revenue Growth
- CTEV N/A
- ITOS 177.89
- 52 Week Low
- CTEV $4.80
- ITOS $6.67
- 52 Week High
- CTEV $37.60
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- CTEV N/A
- ITOS 42.01
- Support Level
- CTEV N/A
- ITOS $6.73
- Resistance Level
- CTEV N/A
- ITOS $7.65
- Average True Range (ATR)
- CTEV 0.00
- ITOS 0.36
- MACD
- CTEV 0.00
- ITOS -0.01
- Stochastic Oscillator
- CTEV 0.00
- ITOS 21.43
About CTEV CLARITEV CORPORATION
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.